SAN DIEGO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- , (“BlossomHill Therapeutics”), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop innovative small mo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results